APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Protein Expression and Purification

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Recombinant Protein Expression and Purification Market Outlook and Growth Opportunities 2026

Report ID 174227820415 April 2026Not stated

Choose your research edition.

Industry ResearchRecombinant Protein Expression and Purification Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Protein Expression and Purification Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Recombinant Protein Expression and Purification Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Protein Expression and Purification Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Recombinant Protein Expression and Purification Market Analysis and Forecast 2026-2032242 pages · $4,950 USD

Market perspective

The global Recombinant Protein Expression and Purification market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Recombinant Protein Expression and Purification is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Protein Expression and Purification is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Protein Expression and Purification is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Recombinant Protein Expression and Purification market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Recombinant Protein Expression and Purification market include Charles River, Biomatik, R&D Systems, Applied Biological Materials Inc. (abm), VectorBuilder, BiologicsCorp, Proteos, RayBiotech and Leinco Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Recombinant Protein Expression and Purification market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Protein Expression and Purification and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Protein Expression and Purification revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Recombinant Protein Expression and Purification market.

Recombinant Protein Expression and Purification Segment by Company

Charles River

Biomatik

R&D Systems

Applied Biological Materials Inc. (abm)

VectorBuilder

BiologicsCorp

Proteos

RayBiotech

Leinco Technologies

Kinexus Bioinformatics

InVivo BioTech Services GmbH

Expression Systems

Creative Biolabs

G&P Biosciences

Eurofins Discovery

Levprot Bioscience

eEnzyme

NorthX Biologics

Jubilant Biosys

GenScript

Boster Bio

Sino Biological

WuXi Biologic

CUSABIO TECHNOLOGY

OriGene Technologies

ProMab Biotechnologies

Creative BioMart

Thermo Fisher Scientific

Recombinant Protein Expression and Purification Segment by Type

Microbial Expression

Mammalian Cell Expression

Others

Recombinant Protein Expression and Purification Segment by Application

Pharmaceutical and Biopharmaceutical Company

Research Laboratory

Hospital

Other

Recombinant Protein Expression and Purification Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Recombinant Protein Expression and Purification status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Recombinant Protein Expression and Purification key companies, revenue, market share, and recent developments.

3. To split the Recombinant Protein Expression and Purification breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Recombinant Protein Expression and Purification market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Recombinant Protein Expression and Purification significant trends, drivers, influence factors in global and regions.

6. To analyze Recombinant Protein Expression and Purification competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Expression and Purification market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Expression and Purification and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Expression and Purification.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Protein Expression and Purification industry.

Chapter 3: Detailed analysis of Recombinant Protein Expression and Purification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Recombinant Protein Expression and Purification in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Recombinant Protein Expression and Purification in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Recombinant Protein Expression and Purification Industry Trends Table 2. Recombinant Protein Expression and Purification Industry Drivers Table 3. Recombinant Protein Expression and Purification Industry Opportunities and Challenges Table 4. Recombinant Protein Expression and Purification Industry Restraints Table 5. Global Recombinant Protein Expression and Purification Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Recombinant Protein Expression and Purification Revenue Share by Company (2021-2026) Table 7. Global Recombinant Protein Expression and Purification Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Recombinant Protein Expression and Purification Key Company Manufacturing Base & Headquarters Table 9. Global Recombinant Protein Expression and Purification Company, Product Type & Application Table 10. Global Recombinant Protein Expression and Purification Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Recombinant Protein Expression and Purification by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Microbial Expression Table 15. Significant Companies of Mammalian Cell Expression Table 16. Significant Companies of Others Table 17. Global Recombinant Protein Expression and Purification Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Recombinant Protein Expression and Purification Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Recombinant Protein Expression and Purification Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Recombinant Protein Expression and Purification Sales Value Share by Type (2021-2026) Table 21. Global Recombinant Protein Expression and Purification Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical and Biopharmaceutical Company Table 23. Significant Companies of Research Laboratory Table 24. Significant Companies of Hospital Table 25. Significant Companies of Other Table 26. Global Recombinant Protein Expression and Purification Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Recombinant Protein Expression and Purification Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Recombinant Protein Expression and Purification Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Recombinant Protein Expression and Purification Sales Value Share by Application (2021-2026) Table 30. Global Recombinant Protein Expression and Purification Sales Value Share by Application (2027-2032) Table 31. Global Recombinant Protein Expression and Purification Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Recombinant Protein Expression and Purification Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Recombinant Protein Expression and Purification Sales Value Share by Region (2021-2026) Table 34. Global Recombinant Protein Expression and Purification Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Recombinant Protein Expression and Purification Sales Value Share by Region (2027-2032) Table 36. Global Recombinant Protein Expression and Purification Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Recombinant Protein Expression and Purification Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Recombinant Protein Expression and Purification Sales Value Market Share by Country (2021-2026) Table 39. Global Recombinant Protein Expression and Purification Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Recombinant Protein Expression and Purification Sales Value Market Share by Country (2027-2032) Table 41. Charles River Company Information Table 42. Charles River Business Overview Table 43. Charles River Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Charles River Recombinant Protein Expression and Purification Product Portfolio Table 45. Charles River Recent Development Table 46. Biomatik Company Information Table 47. Biomatik Business Overview Table 48. Biomatik Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Biomatik Recombinant Protein Expression and Purification Product Portfolio Table 50. Biomatik Recent Development Table 51. R&D Systems Company Information Table 52. R&D Systems Business Overview Table 53. R&D Systems Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. R&D Systems Recombinant Protein Expression and Purification Product Portfolio Table 55. R&D Systems Recent Development Table 56. Applied Biological Materials Inc. (abm) Company Information Table 57. Applied Biological Materials Inc. (abm) Business Overview Table 58. Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Product Portfolio Table 60. Applied Biological Materials Inc. (abm) Recent Development Table 61. VectorBuilder Company Information Table 62. VectorBuilder Business Overview Table 63. VectorBuilder Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. VectorBuilder Recombinant Protein Expression and Purification Product Portfolio Table 65. VectorBuilder Recent Development Table 66. BiologicsCorp Company Information Table 67. BiologicsCorp Business Overview Table 68. BiologicsCorp Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. BiologicsCorp Recombinant Protein Expression and Purification Product Portfolio Table 70. BiologicsCorp Recent Development Table 71. Proteos Company Information Table 72. Proteos Business Overview Table 73. Proteos Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Proteos Recombinant Protein Expression and Purification Product Portfolio Table 75. Proteos Recent Development Table 76. RayBiotech Company Information Table 77. RayBiotech Business Overview Table 78. RayBiotech Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. RayBiotech Recombinant Protein Expression and Purification Product Portfolio Table 80. RayBiotech Recent Development Table 81. Leinco Technologies Company Information Table 82. Leinco Technologies Business Overview Table 83. Leinco Technologies Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Leinco Technologies Recombinant Protein Expression and Purification Product Portfolio Table 85. Leinco Technologies Recent Development Table 86. Kinexus Bioinformatics Company Information Table 87. Kinexus Bioinformatics Business Overview Table 88. Kinexus Bioinformatics Recombinant Protein Expression and Purification Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Kinexus Bioinformatics Recombinant Protein Expression and Purification Product Portfolio Table 90. Kinexus Bioinformatics Recent Development Table 91. InVivo BioTech Services GmbH Company Information Table 92. InVivo BioTech Services GmbH Business Overview Table 93. InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Product Portfolio Table 95. InVivo BioTech Services GmbH Recent Development Table 96. Expression Systems Company Information Table 97. Expression Systems Business Overview Table 98. Expression Systems Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Expression Systems Recombinant Protein Expression and Purification Product Portfolio Table 100. Expression Systems Recent Development Table 101. Creative Biolabs Company Information Table 102. Creative Biolabs Business Overview Table 103. Creative Biolabs Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Creative Biolabs Recombinant Protein Expression and Purification Product Portfolio Table 105. Creative Biolabs Recent Development Table 106. G&P Biosciences Company Information Table 107. G&P Biosciences Business Overview Table 108. G&P Biosciences Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. G&P Biosciences Recombinant Protein Expression and Purification Product Portfolio Table 110. G&P Biosciences Recent Development Table 111. Eurofins Discovery Company Information Table 112. Eurofins Discovery Business Overview Table 113. Eurofins Discovery Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Eurofins Discovery Recombinant Protein Expression and Purification Product Portfolio Table 115. Eurofins Discovery Recent Development Table 116. Levprot Bioscience Company Information Table 117. Levprot Bioscience Business Overview Table 118. Levprot Bioscience Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Levprot Bioscience Recombinant Protein Expression and Purification Product Portfolio Table 120. Levprot Bioscience Recent Development Table 121. eEnzyme Company Information Table 122. eEnzyme Business Overview Table 123. eEnzyme Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. eEnzyme Recombinant Protein Expression and Purification Product Portfolio Table 125. eEnzyme Recent Development Table 126. NorthX Biologics Company Information Table 127. NorthX Biologics Business Overview Table 128. NorthX Biologics Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. NorthX Biologics Recombinant Protein Expression and Purification Product Portfolio Table 130. NorthX Biologics Recent Development Table 131. Jubilant Biosys Company Information Table 132. Jubilant Biosys Business Overview Table 133. Jubilant Biosys Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Jubilant Biosys Recombinant Protein Expression and Purification Product Portfolio Table 135. Jubilant Biosys Recent Development Table 136. GenScript Company Information Table 137. GenScript Business Overview Table 138. GenScript Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. GenScript Recombinant Protein Expression and Purification Product Portfolio Table 140. GenScript Recent Development Table 141. Boster Bio Company Information Table 142. Boster Bio Business Overview Table 143. Boster Bio Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Boster Bio Recombinant Protein Expression and Purification Product Portfolio Table 145. Boster Bio Recent Development Table 146. Sino Biological Company Information Table 147. Sino Biological Business Overview Table 148. Sino Biological Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Sino Biological Recombinant Protein Expression and Purification Product Portfolio Table 150. Sino Biological Recent Development Table 151. WuXi Biologic Company Information Table 152. WuXi Biologic Business Overview Table 153. WuXi Biologic Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. WuXi Biologic Recombinant Protein Expression and Purification Product Portfolio Table 155. WuXi Biologic Recent Development Table 156. CUSABIO TECHNOLOGY Company Information Table 157. CUSABIO TECHNOLOGY Business Overview Table 158. CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Product Portfolio Table 160. CUSABIO TECHNOLOGY Recent Development Table 161. OriGene Technologies Company Information Table 162. OriGene Technologies Business Overview Table 163. OriGene Technologies Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. OriGene Technologies Recombinant Protein Expression and Purification Product Portfolio Table 165. OriGene Technologies Recent Development Table 166. ProMab Biotechnologies Company Information Table 167. ProMab Biotechnologies Business Overview Table 168. ProMab Biotechnologies Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. ProMab Biotechnologies Recombinant Protein Expression and Purification Product Portfolio Table 170. ProMab Biotechnologies Recent Development Table 171. Creative BioMart Company Information Table 172. Creative BioMart Business Overview Table 173. Creative BioMart Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Creative BioMart Recombinant Protein Expression and Purification Product Portfolio Table 175. Creative BioMart Recent Development Table 176. Thermo Fisher Scientific Company Information Table 177. Thermo Fisher Scientific Business Overview Table 178. Thermo Fisher Scientific Recombinant Protein Expression and Purification Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Thermo Fisher Scientific Recombinant Protein Expression and Purification Product Portfolio Table 180. Thermo Fisher Scientific Recent Development Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Recombinant Protein Expression and Purification Product Image Figure 2. Global Recombinant Protein Expression and Purification Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Protein Expression and Purification Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Protein Expression and Purification Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Microbial Expression Image Figure 8. Mammalian Cell Expression Image Figure 9. Others Image Figure 10. Global Recombinant Protein Expression and Purification Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Recombinant Protein Expression and Purification Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Recombinant Protein Expression and Purification Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical and Biopharmaceutical Company Image Figure 14. Research Laboratory Image Figure 15. Hospital Image Figure 16. Other Image Figure 17. Global Recombinant Protein Expression and Purification Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Recombinant Protein Expression and Purification Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Recombinant Protein Expression and Purification Sales Value Share by Application (2021-2032) Figure 20. Global Recombinant Protein Expression and Purification Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Recombinant Protein Expression and Purification Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Recombinant Protein Expression and Purification Sales Value (2021-2032) & (US$ Million) Figure 23. North America Recombinant Protein Expression and Purification Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Recombinant Protein Expression and Purification Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Recombinant Protein Expression and Purification Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Recombinant Protein Expression and Purification Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Recombinant Protein Expression and Purification Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Recombinant Protein Expression and Purification Sales Value (2021-2032) & (US$ Million) Figure 29. South America Recombinant Protein Expression and Purification Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Recombinant Protein Expression and Purification Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Recombinant Protein Expression and Purification Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Microbial Expression
  • Mammalian Cell Expression
  • Others
Applications
  • Pharmaceutical and Biopharmaceutical Company
  • Research Laboratory
  • Hospital
  • Other
Companies covered
  • Charles River
  • Biomatik
  • R&D Systems
  • Applied Biological Materials Inc. (abm)
  • VectorBuilder
  • BiologicsCorp
  • Proteos
  • RayBiotech
  • Leinco Technologies
  • Kinexus Bioinformatics
  • InVivo BioTech Services GmbH
  • Expression Systems
  • Creative Biolabs
  • G&P Biosciences
  • Eurofins Discovery
  • Levprot Bioscience
  • eEnzyme
  • NorthX Biologics
  • Jubilant Biosys
  • GenScript
  • Boster Bio
  • Sino Biological
  • WuXi Biologic
  • CUSABIO TECHNOLOGY
  • OriGene Technologies
  • ProMab Biotechnologies
  • Creative BioMart
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Protein Expression and Purification Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Protein Expression and Purification Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Recombinant Protein Expression and Purification Market Dynamics
  1. 2.1 Recombinant Protein Expression and Purification Industry Trends
  2. 2.2 Recombinant Protein Expression and Purification Industry Drivers
  3. 2.3 Recombinant Protein Expression and Purification Industry Opportunities and Challenges
  4. 2.4 Recombinant Protein Expression and Purification Industry Restraints
3 Recombinant Protein Expression and Purification Market by Company
  1. 3.1 Global Recombinant Protein Expression and Purification Company Revenue Ranking in 2025
  2. 3.2 Global Recombinant Protein Expression and Purification Revenue by Company (2021-2026)
  3. 3.3 Global Recombinant Protein Expression and Purification Company Ranking (2024-2026)
  4. 3.4 Global Recombinant Protein Expression and Purification Company Manufacturing Base and Headquarters
  5. 3.5 Global Recombinant Protein Expression and Purification Company Product Type and Application
  6. 3.6 Global Recombinant Protein Expression and Purification Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Recombinant Protein Expression and Purification Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Recombinant Protein Expression and Purification Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Recombinant Protein Expression and Purification Market by Type
  1. 4.1 Recombinant Protein Expression and Purification Type Introduction
  2. 4.1.1 Microbial Expression
  3. 4.1.2 Mammalian Cell Expression
  4. 4.1.3 Others
  5. 4.2 Global Recombinant Protein Expression and Purification Sales Value by Type
  6. 4.2.1 Global Recombinant Protein Expression and Purification Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Protein Expression and Purification Sales Value by Type (2021-2032)
  8. 4.2.3 Global Recombinant Protein Expression and Purification Sales Value Share by Type (2021-2032)
5 Recombinant Protein Expression and Purification Market by Application
  1. 5.1 Recombinant Protein Expression and Purification Application Introduction
  2. 5.1.1 Pharmaceutical and Biopharmaceutical Company
  3. 5.1.2 Research Laboratory
  4. 5.1.3 Hospital
  5. 5.1.4 Other
  6. 5.2 Global Recombinant Protein Expression and Purification Sales Value by Application
  7. 5.2.1 Global Recombinant Protein Expression and Purification Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Recombinant Protein Expression and Purification Sales Value by Application (2021-2032)
  9. 5.2.3 Global Recombinant Protein Expression and Purification Sales Value Share by Application (2021-2032)
6 Recombinant Protein Expression and Purification Regional Value Analysis
  1. 6.1 Global Recombinant Protein Expression and Purification Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Protein Expression and Purification Sales Value by Region (2021-2032)
  3. 6.2.1 Global Recombinant Protein Expression and Purification Sales Value by Region: 2021-2026
  4. 6.2.2 Global Recombinant Protein Expression and Purification Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Protein Expression and Purification Sales Value (2021-2032)
  7. 6.3.2 North America Recombinant Protein Expression and Purification Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Recombinant Protein Expression and Purification Sales Value (2021-2032)
  10. 6.4.2 Europe Recombinant Protein Expression and Purification Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Recombinant Protein Expression and Purification Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Recombinant Protein Expression and Purification Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Recombinant Protein Expression and Purification Sales Value (2021-2032)
  16. 6.6.2 South America Recombinant Protein Expression and Purification Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Recombinant Protein Expression and Purification Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Recombinant Protein Expression and Purification Sales Value Share by Country, 2025 VS 2032
7 Recombinant Protein Expression and Purification Country-level Value Analysis
  1. 7.1 Global Recombinant Protein Expression and Purification Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Recombinant Protein Expression and Purification Sales Value by Country (2021-2032)
  3. 7.2.1 Global Recombinant Protein Expression and Purification Sales Value by Country (2021-2026)
  4. 7.2.2 Global Recombinant Protein Expression and Purification Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Recombinant Protein Expression and Purification Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Recombinant Protein Expression and Purification Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Recombinant Protein Expression and Purification Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Recombinant Protein Expression and Purification Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Biomatik
  8. 8.2.1 Biomatik Company Information
  9. 8.2.2 Biomatik Business Overview
  10. 8.2.3 Biomatik Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biomatik Recombinant Protein Expression and Purification Product Portfolio
  12. 8.2.5 Biomatik Recent Developments
  13. 8.3 R&D Systems
  14. 8.3.1 R&D Systems Company Information
  15. 8.3.2 R&D Systems Business Overview
  16. 8.3.3 R&D Systems Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  17. 8.3.4 R&D Systems Recombinant Protein Expression and Purification Product Portfolio
  18. 8.3.5 R&D Systems Recent Developments
  19. 8.4 Applied Biological Materials Inc. (abm)
  20. 8.4.1 Applied Biological Materials Inc. (abm) Company Information
  21. 8.4.2 Applied Biological Materials Inc. (abm) Business Overview
  22. 8.4.3 Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Applied Biological Materials Inc. (abm) Recombinant Protein Expression and Purification Product Portfolio
  24. 8.4.5 Applied Biological Materials Inc. (abm) Recent Developments
  25. 8.5 VectorBuilder
  26. 8.5.1 VectorBuilder Company Information
  27. 8.5.2 VectorBuilder Business Overview
  28. 8.5.3 VectorBuilder Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  29. 8.5.4 VectorBuilder Recombinant Protein Expression and Purification Product Portfolio
  30. 8.5.5 VectorBuilder Recent Developments
  31. 8.6 BiologicsCorp
  32. 8.6.1 BiologicsCorp Company Information
  33. 8.6.2 BiologicsCorp Business Overview
  34. 8.6.3 BiologicsCorp Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BiologicsCorp Recombinant Protein Expression and Purification Product Portfolio
  36. 8.6.5 BiologicsCorp Recent Developments
  37. 8.7 Proteos
  38. 8.7.1 Proteos Company Information
  39. 8.7.2 Proteos Business Overview
  40. 8.7.3 Proteos Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Proteos Recombinant Protein Expression and Purification Product Portfolio
  42. 8.7.5 Proteos Recent Developments
  43. 8.8 RayBiotech
  44. 8.8.1 RayBiotech Company Information
  45. 8.8.2 RayBiotech Business Overview
  46. 8.8.3 RayBiotech Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RayBiotech Recombinant Protein Expression and Purification Product Portfolio
  48. 8.8.5 RayBiotech Recent Developments
  49. 8.9 Leinco Technologies
  50. 8.9.1 Leinco Technologies Company Information
  51. 8.9.2 Leinco Technologies Business Overview
  52. 8.9.3 Leinco Technologies Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Leinco Technologies Recombinant Protein Expression and Purification Product Portfolio
  54. 8.9.5 Leinco Technologies Recent Developments
  55. 8.10 Kinexus Bioinformatics
  56. 8.10.1 Kinexus Bioinformatics Company Information
  57. 8.10.2 Kinexus Bioinformatics Business Overview
  58. 8.10.3 Kinexus Bioinformatics Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kinexus Bioinformatics Recombinant Protein Expression and Purification Product Portfolio
  60. 8.10.5 Kinexus Bioinformatics Recent Developments
  61. 8.11 InVivo BioTech Services GmbH
  62. 8.11.1 InVivo BioTech Services GmbH Company Information
  63. 8.11.2 InVivo BioTech Services GmbH Business Overview
  64. 8.11.3 InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  65. 8.11.4 InVivo BioTech Services GmbH Recombinant Protein Expression and Purification Product Portfolio
  66. 8.11.5 InVivo BioTech Services GmbH Recent Developments
  67. 8.12 Expression Systems
  68. 8.12.1 Expression Systems Company Information
  69. 8.12.2 Expression Systems Business Overview
  70. 8.12.3 Expression Systems Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Expression Systems Recombinant Protein Expression and Purification Product Portfolio
  72. 8.12.5 Expression Systems Recent Developments
  73. 8.13 Creative Biolabs
  74. 8.13.1 Creative Biolabs Company Information
  75. 8.13.2 Creative Biolabs Business Overview
  76. 8.13.3 Creative Biolabs Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Creative Biolabs Recombinant Protein Expression and Purification Product Portfolio
  78. 8.13.5 Creative Biolabs Recent Developments
  79. 8.14 G&P Biosciences
  80. 8.14.1 G&P Biosciences Company Information
  81. 8.14.2 G&P Biosciences Business Overview
  82. 8.14.3 G&P Biosciences Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  83. 8.14.4 G&P Biosciences Recombinant Protein Expression and Purification Product Portfolio
  84. 8.14.5 G&P Biosciences Recent Developments
  85. 8.15 Eurofins Discovery
  86. 8.15.1 Eurofins Discovery Company Information
  87. 8.15.2 Eurofins Discovery Business Overview
  88. 8.15.3 Eurofins Discovery Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eurofins Discovery Recombinant Protein Expression and Purification Product Portfolio
  90. 8.15.5 Eurofins Discovery Recent Developments
  91. 8.16 Levprot Bioscience
  92. 8.16.1 Levprot Bioscience Company Information
  93. 8.16.2 Levprot Bioscience Business Overview
  94. 8.16.3 Levprot Bioscience Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Levprot Bioscience Recombinant Protein Expression and Purification Product Portfolio
  96. 8.16.5 Levprot Bioscience Recent Developments
  97. 8.17 eEnzyme
  98. 8.17.1 eEnzyme Company Information
  99. 8.17.2 eEnzyme Business Overview
  100. 8.17.3 eEnzyme Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  101. 8.17.4 eEnzyme Recombinant Protein Expression and Purification Product Portfolio
  102. 8.17.5 eEnzyme Recent Developments
  103. 8.18 NorthX Biologics
  104. 8.18.1 NorthX Biologics Company Information
  105. 8.18.2 NorthX Biologics Business Overview
  106. 8.18.3 NorthX Biologics Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  107. 8.18.4 NorthX Biologics Recombinant Protein Expression and Purification Product Portfolio
  108. 8.18.5 NorthX Biologics Recent Developments
  109. 8.19 Jubilant Biosys
  110. 8.19.1 Jubilant Biosys Company Information
  111. 8.19.2 Jubilant Biosys Business Overview
  112. 8.19.3 Jubilant Biosys Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Jubilant Biosys Recombinant Protein Expression and Purification Product Portfolio
  114. 8.19.5 Jubilant Biosys Recent Developments
  115. 8.20 GenScript
  116. 8.20.1 GenScript Company Information
  117. 8.20.2 GenScript Business Overview
  118. 8.20.3 GenScript Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  119. 8.20.4 GenScript Recombinant Protein Expression and Purification Product Portfolio
  120. 8.20.5 GenScript Recent Developments
  121. 8.21 Boster Bio
  122. 8.21.1 Boster Bio Company Information
  123. 8.21.2 Boster Bio Business Overview
  124. 8.21.3 Boster Bio Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Boster Bio Recombinant Protein Expression and Purification Product Portfolio
  126. 8.21.5 Boster Bio Recent Developments
  127. 8.22 Sino Biological
  128. 8.22.1 Sino Biological Company Information
  129. 8.22.2 Sino Biological Business Overview
  130. 8.22.3 Sino Biological Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Sino Biological Recombinant Protein Expression and Purification Product Portfolio
  132. 8.22.5 Sino Biological Recent Developments
  133. 8.23 WuXi Biologic
  134. 8.23.1 WuXi Biologic Company Information
  135. 8.23.2 WuXi Biologic Business Overview
  136. 8.23.3 WuXi Biologic Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  137. 8.23.4 WuXi Biologic Recombinant Protein Expression and Purification Product Portfolio
  138. 8.23.5 WuXi Biologic Recent Developments
  139. 8.24 CUSABIO TECHNOLOGY
  140. 8.24.1 CUSABIO TECHNOLOGY Company Information
  141. 8.24.2 CUSABIO TECHNOLOGY Business Overview
  142. 8.24.3 CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  143. 8.24.4 CUSABIO TECHNOLOGY Recombinant Protein Expression and Purification Product Portfolio
  144. 8.24.5 CUSABIO TECHNOLOGY Recent Developments
  145. 8.25 OriGene Technologies
  146. 8.25.1 OriGene Technologies Company Information
  147. 8.25.2 OriGene Technologies Business Overview
  148. 8.25.3 OriGene Technologies Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  149. 8.25.4 OriGene Technologies Recombinant Protein Expression and Purification Product Portfolio
  150. 8.25.5 OriGene Technologies Recent Developments
  151. 8.26 ProMab Biotechnologies
  152. 8.26.1 ProMab Biotechnologies Company Information
  153. 8.26.2 ProMab Biotechnologies Business Overview
  154. 8.26.3 ProMab Biotechnologies Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  155. 8.26.4 ProMab Biotechnologies Recombinant Protein Expression and Purification Product Portfolio
  156. 8.26.5 ProMab Biotechnologies Recent Developments
  157. 8.27 Creative BioMart
  158. 8.27.1 Creative BioMart Company Information
  159. 8.27.2 Creative BioMart Business Overview
  160. 8.27.3 Creative BioMart Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Creative BioMart Recombinant Protein Expression and Purification Product Portfolio
  162. 8.27.5 Creative BioMart Recent Developments
  163. 8.28 Thermo Fisher Scientific
  164. 8.28.1 Thermo Fisher Scientific Company Information
  165. 8.28.2 Thermo Fisher Scientific Business Overview
  166. 8.28.3 Thermo Fisher Scientific Recombinant Protein Expression and Purification Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Thermo Fisher Scientific Recombinant Protein Expression and Purification Product Portfolio
  168. 8.28.5 Thermo Fisher Scientific Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst